Natriuretic peptides in heart failure: Improving diagnosis and management of the syndrome

Revista Espanola de Cardiologia

Volumn 55, Issue 1, 2002, Pages 4-6

  Salomone, Óscar Alejandro ^a  

^a HOSPITAL PRIVADO   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC FACTOR; NATRIURETIC PEPTIDE TYPE C; NEUROHORMONE;

CLINICAL OBSERVATION; CONTROLLED STUDY; EDITORIAL; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HUMAN; NEUROENDOCRINOLOGY; PATIENT CARE; SPAIN; BLOOD; CONGESTIVE HEART FAILURE; NOTE; SYNDROME;

HEART FAILURE, CONGESTIVE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; SYNDROME;

EID: 0036007863     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-8932(02)76546-9     Document Type: Editorial

References (9)

1. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for descompensated heart failure
2. Do patients with suspected heart failure and preserved left ventricular systolic function suffer from "diastolic heart failure" or from misdiagnosis? A prospective descriptive study
3. Péptido cerebral natriurético. Valor diagnóstico en la insuficiencia cardíaca
4. Biochemical detection of left ventricular systolic dysfunction
5. Utility of B-type natriuretic peptide in the disgnosis of congestive heart failure in an urgent-care setting
6. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care
7. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations
8. Effect of the angiotensin receptor blocker valsartan on morbidity and mortality in heart failure: The Valsartan Heart Failure Trial (Val-HeFT)
9. Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern